From the aDepartment of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA
bDana Farber/Boston Children’s Cancer and Blood Disorders Center, Boston, MA
cDepartment of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA
dChanning Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA
eDepartment of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA.
Submitted May 31, 2022; accepted January 24, 2023
The results reported herein correspond to specific aims of grant K01ES032458 to Dr. Rachel C. Nethery from the National Institutes of Health.
The authors report no conflicts of interest.
While our data user agreement prohibits us from re-distributing the National Program of Cancer Registries data used in this paper, they are publicly available by request through the US Centers for Disease Control and Prevention (CDC) website (https://www.cdc.gov/cancer/npcr/). R code that can be used to reproduce all data processing and analyses is available at https://github.com/rachelnethery/evaluate_msat.
Supplemental digital content is available through direct URL citations in the HTML and PDF versions of this article (www.epidem.com).
Correspondence: Rachel C. Nethery, Department of Biostatistics, Harvard T.H. Chan School of Public Health, 655 Huntington Ave., Building 2, 4th Floor, Boston, MA 02115. E-mail: [email protected].
